NFKB1 and central nervous system cancer: Radial migration assay demonstrated that functional inhibition of NF-κB using the BAY-11-7082 in glioma cells reduces cell migration by ∼85-100% (P<0.0001: Figure 8C) relative to vehicle (DMSO) treated or untreated cells.